Showing 6,741 - 6,760 results of 6,841 for search '"Japan"', query time: 0.09s Refine Results
  1. 6741

    Understanding Community Health Care Through Problem-Based Learning With Real-Patient Videos: Single-Arm Pre-Post Mixed Methods Study by Kiyoshi Shikino, Kazuyo Yamauchi, Nobuyuki Araki, Ikuo Shimizu, Hajime Kasai, Tomoko Tsukamoto, Hiroshi Tajima, Yu Li, Misaki Onodera, Shoichi Ito

    Published 2025-01-01
    “… BackgroundJapan faces a health care delivery challenge due to physician maldistribution, with insufficient physicians practicing in rural areas. …”
    Get full text
    Article
  2. 6742
  3. 6743
  4. 6744
  5. 6745
  6. 6746
  7. 6747

    Predictive Factors and the Predictive Scoring System for Falls in Acute Care Inpatients: Retrospective Cohort Study by Chihiro Saito, Eiji Nakatani, Hatoko Sasaki, Naoko E Katsuki, Masaki Tago, Kiyoshi Harada

    Published 2025-01-01
    “…ConclusionsWe developed a new fall prediction scoring system for patients admitted to acute care hospitals by identifying predictors of falls in Japan. This system may be useful for preventive interventions in patient populations with a high likelihood of falling in acute care settings.…”
    Get full text
    Article
  8. 6748
  9. 6749
  10. 6750
  11. 6751
  12. 6752

    Laboratory evaluation of oral fluid for syphilis screening among clinic users from Lima, Peru by Jazmin Qquellon, Silver K. Vargas, Francesca Vasquez, E. Michael Reyes-Diaz, Kelika A. Konda, Carlos F. Caceres, Jeffrey D. Klausner

    Published 2025-01-01
    “…Serum was also tested using RPR (RPR slide test, Wiener Laboratorios SAIC, Argentina) and TPPA (Serodia, Fujirebio Diagnostics Inc., Japan). We assessed oral fluid rapid test overall percent agreement, sensitivity, specificity, and Kappa coefficient against serum SD Bioline Syphilis, TPPA, and RPR. …”
    Get full text
    Article
  13. 6753
  14. 6754
  15. 6755
  16. 6756

    Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review by Chao Wang, Yunzhuo Dong, Peng Men, Ruixia Zhang, Ying Xiao, Yishan Bu, Yinpeng Qin, Xinran Zhang, Qianqian Dou, Yiheng Yang, Huier Gao, Yi Zhang

    Published 2025-01-01
    “…The economic researches conducted in China, United States, Japan, Italy and Norway had demonstrated that obinutuzumab-based chemothrepy was cost-effective compared to other chemothrepies. …”
    Get full text
    Article
  17. 6757
  18. 6758

    Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment incl... by Hidekazu Hirano, Naoki Takahashi, Yusuke Amanuma, Nobumi Suzuki, Daisuke Takahari, Takeshi Kawakami, Chie Kudo-Saito, Kengo Nagashima, Narikazu Boku, Ken Kato, Hirokazu Shoji

    Published 2025-02-01
    “…Methods The PADDLE trial, which is sponsored by Ono Pharmaceutical, is an investigator-initiated, multicenter, open-label, single-arm, prospective phase II trial conducted at six institutions in Japan. Key eligibility criteria are as follows: (1) advanced gastric or esophagogastric junction cancer, (2) histologically confirmed diagnosis of adenocarcinoma, (3) refractory to first-line treatment including fluoropyrimidines, platinum, and an anti-PD-1/PD-L1 antibody, (4) performance status of 0–1, and (5) at least one measurable lesion. …”
    Get full text
    Article
  19. 6759
  20. 6760

    The Suppression of Signal Transducer and Activator of Transcription-3 in A549 human Lung Carcinoma Cells Induced by Marine Sponge Callyspongia aerizusa by Hadisaputri YE, Nurhaniefah AA, Mutakin M, Hendriani R, Rezano A, Sopyan I, Yusnaini Y, Asikin Y, Abdulah R

    Published 2025-01-01
    “…Yuni Elsa Hadisaputri,1,* Annida Adha Nurhaniefah,1,* Mutakin Mutakin,2 Rini Hendriani,3 Andri Rezano,4 Iyan Sopyan,5 Yusnaini Yusnaini,6 Yonathan Asikin,7 Rizky Abdulah3 1Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia; 2Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia; 3Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia; 4Department of Biomedical Sciences, Cell Biology Division, Faculty of Medicine, Universitas Padjadjaran, Jatinangor, Indonesia; 5Department of Pharmaceutical and Pharmacy Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia; 6Faculty of Fisheries and Marine Sciences, Universitas Halu Oleo, Kendari, Indonesia; 7Department of Bioscience and Biotechnology, Faculty of Agriculture, University of the Ryukyus, Okinawa, Japan*These authors contributed equally to this workCorrespondence: Yuni Elsa Hadisaputri, Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Jl. …”
    Get full text
    Article